Institution
Kansai Medical University Hospital
Also known as: 関西医科大学附属病院
- 136running trials
- 41closed trials
- 1,514publications (OpenAlex)
Running trials
Recruiting
Recruiting
A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Phase 2 Bridging Study of Elacestrant Monotherapy in Advanced or Metastatic Breast Cancer
Recruiting
Safety, Dosage, and Microbiome Engraftment Study of MGT-006 for Ulcerative Colitis (ROOT Study)
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Recruiting
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
Recruiting
Recruiting
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Recruiting
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Active, not recruiting
P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Recruiting
Recruiting
Recruiting
Recruiting
Showing 50 of 136.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer43 recruiting
- Metastatic breast cancer7 recruiting
- Colorectal cancer5 recruiting
- Head and neck cancer4 recruiting
- Ovarian cancer3 recruiting
- Prostate cancer3 recruiting
- Acute myeloid leukaemia2 recruiting
- Crohn's disease2 recruiting
- Diffuse large B-cell lymphoma2 recruiting
- Endometrial cancer2 recruiting
- Immune thrombocytopenia (ITP)2 recruiting
- Liver and biliary tract cancer2 recruiting
- Pancreatic cancer2 recruiting
- Stroke2 recruiting
- Triple-negative breast cancer2 recruiting
- Ulcerative colitis2 recruiting
- Bladder cancer1 recruiting
- Cervical cancer1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Chronic rhinosinusitis with nasal polyps1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Haemophilia1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Neuroendocrine tumours1 recruiting
- Sarcoma1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Observational Study of Patients With Moderate to Severe Chronic Plaque Psoriasis
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC
Registry name variants (66)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Kansai Medical University Hospital
Hirakata, Osaka 573-1191
65 trials
Kansai Medical University Hospital
Hirakata-shi, Osaka 573-1191
29 trials
Kansai Medical University Hospital
Osaka, 573-1191
13 trials
Kansai Medical University Hospital
Osaka, Hirakata, 573-1191
6 trials
Kansai Medical University Hospital (Site 0804)
Hirakata, Osaka 573-1191
2 trials
Kansai Medical University Hospital (Site 4408)
Hirakata, Osaka 573-1191
2 trials
Kansai Medical University Hirakata Hospital
Hirakata-shi, Osaka 573-1191
1 trial
Kansai Medical University Hirakata Hospital
Hirakata-shi, Osaka 573-1191
1 trial
Kansai Medical University Hospital Department of Respiratory Oncology
Hirakata, Osaka
1 trial
Kansai Medical University Hospital_Hematology-Oncology
Hirakata-shi, Osaka, 573-1191
1 trial
NCT07830732A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A
Contact: Novo Nordisk
Kansai Medical University Hospital
Hirakata-shi, Osaka 573-1191
1 trial
Kansai Medical University Hospital
Hirakata-shi, Osaka 573-1191
1 trial
Kansai Medical University Hospital
Hirakata-shi, Osaka 573-1191
1 trial
Kansai Medical University Hospital
Hirakata-shi, Osaka 573-1191
1 trial
Kansai Medical University Hospital
Hirakata-shi, Osaka 573-1191
1 trial
Kansai Medical University Hospital
Hirakata-shi, Osaka 573-1191
1 trial
Kansai Medical University Hospital
Hirakata-shi, Osaka 573-1191
1 trial
Kansai Medical University Hospital
Hirakata-shi, Osaka 573-1191
1 trial
Kansai Medical University Hospital
Hirakata-shi, Osaka 573-1191
1 trial
Kansai Medical University Hospital
Hirakata-shi, Osaka 573-1191
1 trial
Kansai Medical University Hospital
Hirakata-shi, Osaka 573-1191
1 trial
Kansai Medical University Hospital
Hirakata-shi, Osaka 573-1191
1 trial
Kansai Medical University Hospital
Hirakata-shi, Osaka 573-1191
1 trial
Kansai Medical University Hospital
Hirakata-shi, Osaka 573-1191
1 trial
Kansai Medical University Hospital
Hirakata-shi, Osaka 573-1191
1 trial
Kansai Medical University Hospital
Hirakata-shi, Osaka 573-1191
1 trial
Kansai Medical University Hospital
Hirakata-shi, Osaka 573-1191
1 trial
Kansai Medical University Hospital
Hirakata-shi, Osaka 573-1191
1 trial
Kansai Medical University Hospital
Hirakata-shi, Osaka 573-1191
1 trial
Kansai Medical University Hospital
Hirakata-shi, Osaka 573-1191
1 trial
Contact: AbbVie GK Clinical Trial Registration Desk
Kansai Medical University Hospital
Hirakata-shi, Osaka 573-1191
1 trial
Kansai Medical University Hospital (Site 0005)
Hirakata, Osaka 573-1191
1 trial
Kansai Medical University Hospital (Site 0007)
Hirakata, Osaka 573-1191
1 trial
Kansai Medical University Hospital (Site 0022)
Hirakata, Osaka 573-1191
1 trial
Kansai Medical University Hospital (Site 0104)
Hirakata, Osaka 573-1191
1 trial
Kansai Medical University Hospital (Site 0112)
Hirakata, Osaka 573-1191
1 trial
Kansai Medical University Hospital (Site 0190)
Hirakata, Osaka 573-1191
1 trial
Kansai Medical University Hospital (Site 0607)
Hirakata, Osaka 573-1191
1 trial
Kansai Medical University Hospital (Site 0739)
Hirakata, Osaka 573-1191
1 trial
Kansai Medical University Hospital (Site 0912)
Hirakata, Osaka 573-1191
1 trial
NCT06136624Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Contact: Study Coordinator
Kansai Medical University Hospital (Site 1006)
Hirakata, Osaka 573-1191
1 trial
Kansai Medical University Hospital (Site 1168)
Hirakata, Osaka 573-1191
1 trial
Kansai Medical University Hospital (Site 1207)
Hirakata, Osaka 573-1191
1 trial
Kansai Medical University Hospital (Site 1211)
Hirakata, Osaka 573-1191
1 trial
Kansai Medical University Hospital (Site 2209)
Hirakata, Osaka 573-1191
1 trial
Contact: Study Coordinator
Kansai Medical University Hospital (Site 2317)
Hirakata, Osaka 573-1191
1 trial
Contact: Study Coordinator
Kansai Medical University Hospital (Site 2503)
Hirakata, Osaka 573-1191
1 trial
Kansai Medical University Hospital (Site 2608)
Hirakata, Osaka 573-1191
1 trial
Kansai Medical University Hospital (Site 2618)
Hirakata, Osaka 573-1191
1 trial
Kansai Medical University Hospital (Site 2622)
Hirakata, Osaka 573-1191
1 trial
Kansai Medical University Hospital (Site 2809)
Hirakata, Osaka 573-1191
1 trial
Contact: Study Coordinator
Kansai Medical University Hospital (Site 2823)
Hirakata, Osaka 573-1191
1 trial
Kansai Medical University Hospital (Site 3009)
Hirakata, Osaka 573-1191
1 trial
Kansai Medical University Hospital (Site 3016)
Hirakata, Osaka 573-1191
1 trial
Kansai Medical University Hospital (Site 3103)
Hirakata, Osaka 573-1191
1 trial
Kansai Medical University Hospital (Site 3203)
Hirakata, Osaka 573-1191
1 trial
Kansai Medical University Hospital (Site 3213)
Hirakata, Osaka 573-1191
1 trial
NCT07060807A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Contact: Study Coordinator
Kansai Medical University Hospital (Site 3312)
Hirakata, Osaka 573-1191
1 trial
Kansai Medical University Hospital (Site 3409)
Hirakata, Osaka 573-1191
1 trial
Contact: Study Coordinator
Kansai Medical University Hospital (Site 3410)
Hirakata, Osaka 573-1191
1 trial
Kansai Medical University Hospital (Site 3412)
Hirakata, Osaka 573-1191
1 trial
Kansai Medical University Hospital (Site 3414)
Hirakata, Osaka 573-1191
1 trial
Kansai Medical University Hospital (Site 3607)
Hirakata, Osaka 573-1191
1 trial
Kansai Medical University Hospital (Site 3806)
Hirakata, Osaka 573-1191
1 trial
Kansai Medical University Hospital (Site 4009)
Hirakata, Osaka 573-1191
1 trial
Kansai Medical University Hospital (Site 5004)
Hirakata, Osaka 573-1191
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Haemophilia8 works · 1 trial
Institution data: ROR 04gpc9445 (CC0-1.0)Updated 15 Nov 2026